Heart Transplant and Mechanical Circulatory Support in Patients With Advanced Heart Failure

Cristina Sánchez-Enrique, Ulrich P. Jorde, José González-Costello

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Patients with advanced heart failure have a poor prognosis and heart transplant is still the best treatment option. However, the scarcity of donors, long waiting times, and an increasing number of unstable patients have favored the development of mechanical circulatory support. This review summarizes the indications for heart transplant, candidate evaluation, current immunosuppression strategies, the evaluation and treatment of rejection, infectious prophylaxis, and short and long-term outcomes. Regarding mechanical circulatory support, we distinguish between short- and long-term support and the distinct strategies that can be used: bridge to decision, recovery, candidacy, transplant, and destination therapy. We then discuss indications, risk assessment, management of complications, especially with long-term support, and outcomes. Finally, we discuss future challenges and how the widespread use of long-term support for patients with advanced heart failure will only be viable if their complications and costs are reduced. Full English text available from: www.revespcardiol.org/en

Original languageSpanish
JournalRevista Espanola de Cardiologia
DOIs
StateAccepted/In press - 2017

Keywords

  • Advanced heart failure
  • Heart transplant
  • Mechanical circulatory support

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heart Transplant and Mechanical Circulatory Support in Patients With Advanced Heart Failure. / Sánchez-Enrique, Cristina; Jorde, Ulrich P.; González-Costello, José.

In: Revista Espanola de Cardiologia, 2017.

Research output: Contribution to journalArticle

@article{50eb5877be3d4576a8b71dda921ecab5,
title = "Heart Transplant and Mechanical Circulatory Support in Patients With Advanced Heart Failure",
abstract = "Patients with advanced heart failure have a poor prognosis and heart transplant is still the best treatment option. However, the scarcity of donors, long waiting times, and an increasing number of unstable patients have favored the development of mechanical circulatory support. This review summarizes the indications for heart transplant, candidate evaluation, current immunosuppression strategies, the evaluation and treatment of rejection, infectious prophylaxis, and short and long-term outcomes. Regarding mechanical circulatory support, we distinguish between short- and long-term support and the distinct strategies that can be used: bridge to decision, recovery, candidacy, transplant, and destination therapy. We then discuss indications, risk assessment, management of complications, especially with long-term support, and outcomes. Finally, we discuss future challenges and how the widespread use of long-term support for patients with advanced heart failure will only be viable if their complications and costs are reduced. Full English text available from: www.revespcardiol.org/en",
keywords = "Advanced heart failure, Heart transplant, Mechanical circulatory support",
author = "Cristina S{\'a}nchez-Enrique and Jorde, {Ulrich P.} and Jos{\'e} Gonz{\'a}lez-Costello",
year = "2017",
doi = "10.1016/j.recesp.2016.10.032",
language = "Spanish",
journal = "Revista Espanola de Cardiologia",
issn = "0300-8932",
publisher = "Ediciones Doyma, S.L.",

}

TY - JOUR

T1 - Heart Transplant and Mechanical Circulatory Support in Patients With Advanced Heart Failure

AU - Sánchez-Enrique, Cristina

AU - Jorde, Ulrich P.

AU - González-Costello, José

PY - 2017

Y1 - 2017

N2 - Patients with advanced heart failure have a poor prognosis and heart transplant is still the best treatment option. However, the scarcity of donors, long waiting times, and an increasing number of unstable patients have favored the development of mechanical circulatory support. This review summarizes the indications for heart transplant, candidate evaluation, current immunosuppression strategies, the evaluation and treatment of rejection, infectious prophylaxis, and short and long-term outcomes. Regarding mechanical circulatory support, we distinguish between short- and long-term support and the distinct strategies that can be used: bridge to decision, recovery, candidacy, transplant, and destination therapy. We then discuss indications, risk assessment, management of complications, especially with long-term support, and outcomes. Finally, we discuss future challenges and how the widespread use of long-term support for patients with advanced heart failure will only be viable if their complications and costs are reduced. Full English text available from: www.revespcardiol.org/en

AB - Patients with advanced heart failure have a poor prognosis and heart transplant is still the best treatment option. However, the scarcity of donors, long waiting times, and an increasing number of unstable patients have favored the development of mechanical circulatory support. This review summarizes the indications for heart transplant, candidate evaluation, current immunosuppression strategies, the evaluation and treatment of rejection, infectious prophylaxis, and short and long-term outcomes. Regarding mechanical circulatory support, we distinguish between short- and long-term support and the distinct strategies that can be used: bridge to decision, recovery, candidacy, transplant, and destination therapy. We then discuss indications, risk assessment, management of complications, especially with long-term support, and outcomes. Finally, we discuss future challenges and how the widespread use of long-term support for patients with advanced heart failure will only be viable if their complications and costs are reduced. Full English text available from: www.revespcardiol.org/en

KW - Advanced heart failure

KW - Heart transplant

KW - Mechanical circulatory support

UR - http://www.scopus.com/inward/record.url?scp=85016469226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016469226&partnerID=8YFLogxK

U2 - 10.1016/j.recesp.2016.10.032

DO - 10.1016/j.recesp.2016.10.032

M3 - Article

C2 - 28188009

AN - SCOPUS:85016469226

JO - Revista Espanola de Cardiologia

JF - Revista Espanola de Cardiologia

SN - 0300-8932

ER -